Oncological and aesthetic considerations of skin-sparing mastectomy Neill PataniKefah Mokbel Review 28 October 2007 Pages: 391 - 403
Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women Wei-Tse YangMark DrydenBanu Arun Review 17 November 2007 Pages: 405 - 410
αB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancer Olga IvanovFeng ChenVincent L. Cryns Preclinical Study 30 October 2007 Pages: 411 - 417
NF-κB pathway inhibitors preferentially inhibit breast cancer stem-like cells Jiangbing ZhouHao ZhangYing Zhang Preclinical Study 27 October 2007 Pages: 419 - 427
DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients Inko NimmrichAnieta M. SieuwertsJohn W. M. Martens Preclinical Study 28 October 2007 Pages: 429 - 437
JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer Michael ReedijkDushanthi PinnaduwageIrene L. Andrulis Preclinical Study 08 November 2007 Pages: 439 - 448
A polymorphism in the G protein β3-subunit gene is associated with bone metastasis risk in breast cancer patients H. ClarU. LangsenlehnerR. Windhager Preclinical Study 04 November 2007 Pages: 449 - 452
Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptorβ in primary invasive breast carcinomas Gaynor J. BatesStephen B. FoxAlison H. Banham Preclinical Study 17 November 2007 Pages: 453 - 459
Midregion PTHrP regulates Rip1 and caspase expression in MDA-MB231 breast cancer cells Claudio LuparelloRosalia SirchiaBruna Lo Sasso Preclinical Study 21 November 2007 Pages: 461 - 474
High frequency of HIF-1α overexpression in BRCA1 related breast cancer Petra van der GroepAlwin BouterPaul J. van Diest Preclinical Study 21 November 2007 Pages: 475 - 480
A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk Kathryn E. TalbottMarilie D. GammonHabibul Ahsan Epidemiology 02 November 2007 Pages: 481 - 487
Surveillance mammography and the risk of death among elderly breast cancer patients Mario SchootmanDonna B. JeffeWilliam E. Gillanders Epidemiology 24 October 2007 Pages: 489 - 496
MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish–Ashkenazi descent Ronit I. YardenEitan FriedmanMoshe Zvi Papa Epidemiology 18 November 2007 Pages: 497 - 504
BARD1 variants are not associated with breast cancer risk in Australian familial breast cancer Kylie L. GorringeDavid Y. H. ChoongIan G. Campbell Epidemiology 31 October 2007 Pages: 505 - 509
Tumor-derived CCL5 does not contribute to breast cancer progression Mevan M. JayasingheJacqueline M. GoldenRobert A. Kurt Preclinical study 03 November 2007 Pages: 511 - 521
Brain metastases in breast cancer: prognostic factors and management Sung Sook LeeJin-Hee AhnWoo Kun Kim Epidemiology 08 November 2007 Pages: 523 - 530
Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast Kaire InnosPamela L. Horn-Ross Epidemiology 04 November 2007 Pages: 531 - 540
A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma Salomone Di SaverioJuan GutierrezEli Avisar Epidemiology 18 November 2007 Pages: 541 - 547
Genetic polymorphisms of XRCC1 (codon 399) and susceptibility to breast cancer in Iranian women, a case–control study Mostafa SaadatLeila KohanShahpour Omidvari Epidemiology 07 November 2007 Pages: 549 - 553
Differences in breast cancer biological characteristics between ethnic groups in New Zealand M. K. WestonD. P. MossA. G. Hill Epidemiology 18 November 2007 Pages: 555 - 558
Population attributable risks for breast cancer in Swedish women by morphological type Charlotta GranströmJan SundquistKari Hemminki Epidemiology 08 November 2007 Pages: 559 - 568
ERCC1 expression in triple negative breast carcinoma: the paradox revisited Angelo SidoniFabio CartagineseLucio Crinó Letter to the editor 07 November 2007 Pages: 569 - 570
